Friday, October 2, 2026
Biotech

New Hope for Pompe Disease Patients

New data shows a combination therapy helps adults with Pompe disease keep their motor skills for five years.

BioMarin shares good news for people with Pompe disease. The company released five years of data. This information shows their special treatment helps patients. It lets them keep their motor skills, like walking and moving.

Pompe disease is a rare condition. It weakens muscles over time. The new treatment combines two medicines. It aims to stop the disease from getting worse.

Researchers watched patients for half a decade. The study focused on adults with late-onset Pompe disease. These patients kept their ability to move. This is a big step forward in fighting the disease.

This long-term success brings hope. It means people living with Pompe disease may have more independence. They can continue to perform daily tasks with less difficulty.

Source: CNBC

#Biotech

More from Biotech